Neil Robert Buck,Wouter Claerhout,Bruno H. Leuenberger,Elisabeth Stoecklin,Kai Urban,Swen Wolfram
申请号：
US13840825
公开号：
US20130210782A1
申请日:
2013.03.15
申请国别(地区):
US
年份:
2013
代理人:
摘要：
We disclose treating hyperglycemia in a human with 25-hydroxyyitamin D3 (calcifediol). Blood glucose is reduced to a level which is closer to normal than baseline. Vitamin D3 (cholecalciferol) may optionally be used together with 25-hydroxy vitamin D3. Forms and dosages of a pharmaceutical composition, as well as processes for manufacturing medicaments, are also disclosed.
